Was the reading the PR news on this one this week, since I take an RA drug.....
I was thinking 2 weeks ago, based on my Bio-engineering-Bio-Chem back ground (my older brother mentor was an MD) that RA drugs, Immune suppressants might just limit the COVID19 damage, if I got unlucky and caught it.
Problem is taking it makes me an easy target for COVID19, but taking it protects my joints (I have the RA version of arthritis, bad shit), and may just limit lung damage since most of the Covid19 damage is done by the immune systems over response of trying to kill the virus.
That PR this week got my attention (COvid19/Biotech news) and bang there is, the big boys thinking the same thing I was.
Which reminds me that VEP-Lipsome in a drink by Milv has solid potential for limiting and repair lung cell tissue damage from Covid19 as well. Hang on to those shares tight sir, as the past research says I am right, so if Milv/NDT Pharma comes out with a covid19 supplement drink line approved by UPennMed doctors (the JV partners with Milv) that price could explode 50 fold in days.
I hope to interview management (ungaged management) in a week or so and report back to folks since the Custodian was relieved today, from what I heard(??)
All of my posts are strictly opinions and should not be considered to be facts, or investment advise. They are for entertainment purposes only.
Recent REGN News
- Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Eosinophilic Esophagitis (EoE) in Children as Young as 1 Year Old • GlobeNewswire Inc. • 09/20/2024 11:45:00 AM
- Dupixent® (dupilumab) Approved in the U.S. as First and Only Treatment for Adolescents with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) • GlobeNewswire Inc. • 09/13/2024 04:15:28 PM
- EYLEA HD® (aflibercept) Injection 8 mg Data at EURETINA Reinforce Long-term Durability, Sustained Fluid Control and Safety Profile • GlobeNewswire Inc. • 09/11/2024 11:00:46 AM
- Libtayo® (cemiplimab) Demonstrates Durable Survival Benefit at Five Years in Advanced Non-small Cell Lung Cancer • GlobeNewswire Inc. • 09/09/2024 09:00:00 PM
- Regeneron to Highlight Progress Across Its Differentiated Oncology Portfolio and Pipeline at WCLC and ESMO • GlobeNewswire Inc. • 09/09/2024 11:00:17 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2024 08:01:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2024 08:01:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2024 08:01:10 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/03/2024 08:04:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/29/2024 08:27:40 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/28/2024 08:35:33 PM
- Ordspono™ (odronextamab) Approved in the European Union for the Treatment of Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphoma • GlobeNewswire Inc. • 08/26/2024 11:00:00 AM
- Latest Dupixent® (dupilumab) and Itepekimab Data at ERS Highlight Scientific Innovation and Leadership in Respiratory Diseases • GlobeNewswire Inc. • 08/26/2024 05:00:00 AM
- Regeneron Provides Update on Biologics License Application for Linvoseltamab • GlobeNewswire Inc. • 08/20/2024 10:45:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/19/2024 08:02:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/19/2024 08:01:37 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/15/2024 09:55:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/15/2024 08:01:19 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/15/2024 03:45:34 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/14/2024 08:08:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 08:01:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/12/2024 08:05:11 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/08/2024 08:53:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2024 08:40:11 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/07/2024 08:33:34 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM